Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2022 Filed Mar 2, 2022 23:46 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 38,664 | $41.38 Strike: $41.38 | $1,599,916.32 |
DisclosureSEC source: 0001367644-22-000042 · wf-form4_164626472010733.xml · derivative · entry 4 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,664 Underlying: Common Stock · 38,664 shares Expires 2029-02-28 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:46 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantCommon Stock | 16,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000042 · wf-form4_164626472010733.xml · nonDerivative · entry 2 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,291 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:46 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantCommon Stock | 31,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000042 · wf-form4_164626472010733.xml · nonDerivative · entry 1 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,375 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (9,667 shares) or on the day prior to the second anniversary date of the grant (21,750 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 00:25 UTC |
Kramer RobertDirector · President and CEO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 135,330 | $41.38 Strike: $41.38 | $5,599,955.40 |
DisclosureSEC source: 0001367644-22-000044 · wf-form4_164626713300332.xml · derivative · entry 4 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,330 Underlying: Common Stock · 135,330 shares Expires 2029-02-28 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 00:25 UTC |
Kramer RobertDirector · President and CEO
|
GrantCommon Stock | 55,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000044 · wf-form4_164626713300332.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,684 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 00:25 UTC |
Kramer RobertDirector · President and CEO
|
GrantCommon Stock | 33,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000044 · wf-form4_164626713300332.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,102 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 00:25 UTC |
Havey AdamEVP, Business Operations
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 42,289 | $41.38 Strike: $41.38 | $1,749,918.82 |
DisclosureSEC source: 0001367644-22-000043 · wf-form4_164626708631194.xml · derivative · entry 4 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,289 Underlying: Common Stock · 42,289 shares Expires 2029-02-28 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 00:25 UTC |
Havey AdamEVP, Business Operations
|
GrantCommon Stock | 17,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000043 · wf-form4_164626708631194.xml · nonDerivative · entry 2 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,939 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 00:25 UTC |
Havey AdamEVP, Business Operations
|
GrantCommon Stock | 32,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000043 · wf-form4_164626708631194.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,117 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (10,573 shares) or on the day prior to the second anniversary date of the grant (21,750 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:45 UTC |
SARAN ATULEVP, Chief Strat & Dev Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 38,664 | $41.38 Strike: $41.38 | $1,599,916.32 |
DisclosureSEC source: 0001367644-22-000041 · wf-form4_164626470277626.xml · derivative · entry 4 SARAN ATUL · CIK 0001591070 · EVP, Chief Strat & Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,664 Underlying: Common Stock · 38,664 shares Expires 2029-02-28 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:45 UTC |
SARAN ATULEVP, Chief Strat & Dev Officer
|
GrantCommon Stock | 16,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000041 · wf-form4_164626470277626.xml · nonDerivative · entry 2 SARAN ATUL · CIK 0001591070 · EVP, Chief Strat & Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,546 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:45 UTC |
SARAN ATULEVP, Chief Strat & Dev Officer
|
GrantCommon Stock | 31,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000041 · wf-form4_164626470277626.xml · nonDerivative · entry 1 SARAN ATUL · CIK 0001591070 · EVP, Chief Strat & Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,630 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (9,667 shares) or on the day prior to the second anniversary date of the grant (21,750 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 18:28 UTC |
Fox Jennifer LynneEVP, Ext Aff, GC, Corp Sec
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 26,584 | $41.38 Strike: $41.38 | $1,100,045.92 |
DisclosureSEC source: 0001367644-22-000048 · wf-form4_164635006141702.xml · derivative · entry 3 Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,584 Underlying: Common Stock · 26,584 shares Expires 2029-02-28 F3 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 18:28 UTC |
Fox Jennifer LynneEVP, Ext Aff, GC, Corp Sec
|
GrantCommon Stock | 17,794 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000048 · wf-form4_164635006141702.xml · nonDerivative · entry 2 Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,627 F2 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (8,713 shares) or on the day prior to the second anniversary date of the grant (9,063 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 18:28 UTC |
Fox Jennifer LynneEVP, Ext Aff, GC, Corp Sec
|
GrantCommon Stock | 7,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000048 · wf-form4_164635006141702.xml · nonDerivative · entry 1 Fox Jennifer Lynne · CIK 0001914879 · EVP, Ext Aff, GC, Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,833 F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 18:45 UTC |
Strei KatherineEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 561 | $39.64 | $22,238.04 |
DisclosureSEC source: 0001367644-22-000040 · wf-form4_164626467480687.xml · nonDerivative · entry 3 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,897 F3 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:46 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 818 | $39.64 | $32,425.52 |
DisclosureSEC source: 0001367644-22-000042 · wf-form4_164626472010733.xml · nonDerivative · entry 3 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,473 F3 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:25 UTC |
Kramer RobertDirector · President and CEO
|
Tax withholdingCommon Stock | 1,715 | $39.64 | $67,982.60 |
DisclosureSEC source: 0001367644-22-000044 · wf-form4_164626713300332.xml · nonDerivative · entry 3 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,969 F3 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:25 UTC |
Havey AdamEVP, Business Operations
|
Tax withholdingCommon Stock | 739 | $39.64 | $29,293.96 |
DisclosureSEC source: 0001367644-22-000043 · wf-form4_164626708631194.xml · nonDerivative · entry 3 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,200 F3 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 23:45 UTC |
SARAN ATULEVP, Chief Strat & Dev Officer
|
Tax withholdingCommon Stock | 764 | $39.64 | $30,284.96 |
DisclosureSEC source: 0001367644-22-000041 · wf-form4_164626470277626.xml · nonDerivative · entry 3 SARAN ATUL · CIK 0001591070 · EVP, Chief Strat & Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,782 F3 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 17:19 UTC |
Strei KatherineEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 590 | $42.47 | $25,057.30 |
DisclosureSEC source: 0001367644-22-000034 · wf-form4_164582755230958.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,208 F1 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 22:18 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 983 | $42.47 | $41,748.01 |
DisclosureSEC source: 0001367644-22-000032 · wf-form4_164582747302451.xml · nonDerivative · entry 2 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,958 F1 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 22:19 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
Tax withholdingCommon Stock | 857 | $42.47 | $36,396.79 |
DisclosureSEC source: 0001367644-22-000033 · wf-form4_164582752703351.xml · nonDerivative · entry 2 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,213 F1 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 22:17 UTC |
Havey AdamEVP, Business Operations
|
Tax withholdingCommon Stock | 828 | $42.47 | $35,165.16 |
DisclosureSEC source: 0001367644-22-000030 · wf-form4_164582741558623.xml · nonDerivative · entry 2 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,794 F1 · security: Represents shares of common stock withheld by the company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 22:18 UTC |
Kramer RobertDirector · President and CEO
|
Tax withholdingCommon Stock | 2,034 | $42.47 | $86,383.98 |
DisclosureSEC source: 0001367644-22-000031 · wf-form4_164582744695738.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,269 F1 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 17:19 UTC |
Strei KatherineEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 344 | $42.23 | $14,527.12 |
DisclosureSEC source: 0001367644-22-000034 · wf-form4_164582755230958.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,798 F1 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:18 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 516 | $42.23 | $21,790.68 |
DisclosureSEC source: 0001367644-22-000032 · wf-form4_164582747302451.xml · nonDerivative · entry 1 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,941 F1 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:19 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
Tax withholdingCommon Stock | 442 | $42.23 | $18,665.66 |
DisclosureSEC source: 0001367644-22-000033 · wf-form4_164582752703351.xml · nonDerivative · entry 1 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,070 F1 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:17 UTC |
Havey AdamEVP, Business Operations
|
Tax withholdingCommon Stock | 424 | $42.23 | $17,905.52 |
DisclosureSEC source: 0001367644-22-000030 · wf-form4_164582741558623.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,622 F1 · security: Represents shares of common stock withheld by the company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:18 UTC |
Kramer RobertDirector · President and CEO
|
Tax withholdingCommon Stock | 1,419 | $42.23 | $59,924.37 |
DisclosureSEC source: 0001367644-22-000031 · wf-form4_164582744695738.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,303 F1 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 18:47 UTC |
Strei KatherineEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 1,616 | $42.23 | $68,243.68 |
DisclosureSEC source: 0001367644-22-000014 · wf-form4_164574640464379.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,142 F2 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 18:47 UTC |
Strei KatherineEVP, Chief HR Officer
|
GrantCommon Stock | 1,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000014 · wf-form4_164574640464379.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,758 F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 4,741 shares of common stock, which is in excess of the 3,483 shares previously reported on February 28, 2019. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 23:53 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 2,298 | $42.23 | $97,044.54 |
DisclosureSEC source: 0001367644-22-000020 · wf-form4_164574681773856.xml · nonDerivative · entry 2 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,457 F2 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 23:53 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantCommon Stock | 1,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000020 · wf-form4_164574681773856.xml · nonDerivative · entry 1 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,755 F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 6,917 shares of common stock, which is in excess of the 5,081 shares previously reported on February 28, 2019. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 23:56 UTC |
Kramer RobertDirector · President and CEO
|
Tax withholdingCommon Stock | 4,595 | $42.23 | $194,046.85 |
DisclosureSEC source: 0001367644-22-000022 · wf-form4_164574700044851.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,722 F2 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 23:56 UTC |
Kramer RobertDirector · President and CEO
|
GrantCommon Stock | 4,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000022 · wf-form4_164574700044851.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,317 F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 16,065 shares of common stock, which is in excess of the 11,801 shares previously reported on February 28, 2019. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 23:51 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
Tax withholdingCommon Stock | 2,084 | $42.23 | $88,007.32 |
DisclosureSEC source: 0001367644-22-000018 · wf-form4_164574668094391.xml · nonDerivative · entry 2 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,512 F2 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 23:51 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantCommon Stock | 1,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000018 · wf-form4_164574668094391.xml · nonDerivative · entry 1 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,596 F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 6,917 shares of common stock, which is in excess of the 5,081 shares previously reported on February 28, 2019. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 23:49 UTC |
Havey AdamEVP, Business Operations
|
Tax withholdingCommon Stock | 1,980 | $42.23 | $83,615.40 |
DisclosureSEC source: 0001367644-22-000016 · wf-form4_164574658105150.xml · nonDerivative · entry 2 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,046 F2 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 23:49 UTC |
Havey AdamEVP, Business Operations
|
GrantCommon Stock | 1,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000016 · wf-form4_164574658105150.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,026 F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 6,917 shares of common stock, which is in excess of the 5,081 shares previously reported on February 28, 2019. Read SEC document |
| December 03, 2021 Filed Dec 8, 2021 02:10 UTC |
El-Hibri FuadDirector
|
OtherCommon Stock | 206,434 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-047222 · doc4.xml · nonDerivative · entry 3 El-Hibri Fuad · CIK 0001380185 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 206,434 F1 · kind: On December 3, 2021, each of Intervac L.L.C., a Maryland limited liability company ("Intervac"), and BioVac, L.L.C., a Maryland limited liability company ("BioVac"), effected a pro-rata liquidating distribution to their respective members of shares of the Issuer's common stock for no consideration (the "Distribution"). In prior reports filed by the reporting person pursuant to Section 16, the reporting person reported indirect beneficial ownership over shares of the Issuer's common stock held by Intervac and BioVac. After giving effect to the Distribution, the reporting person no longer has beneficial ownership over 164,610 shares of the Issuer's common stock that was previously reported as beneficially owned by BioVac. F4 · ownership.nature: Held by the El-Hibri Decedents Trust, for which the reporting person serves as the Trustee. The reporting person expressly disclaims beneficial ownership of any shares of the Issuer's common stock owned by the El-Hibri Decendents Trust except to the extent of his pecuniary interest therein. Read SEC document |
| December 03, 2021 Filed Dec 8, 2021 02:10 UTC |
El-Hibri FuadDirector
|
OtherCommon Stock | 274,930 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-047222 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 274,930 F1 · kind: On December 3, 2021, each of Intervac L.L.C., a Maryland limited liability company ("Intervac"), and BioVac, L.L.C., a Maryland limited liability company ("BioVac"), effected a pro-rata liquidating distribution to their respective members of shares of the Issuer's common stock for no consideration (the "Distribution"). In prior reports filed by the reporting person pursuant to Section 16, the reporting person reported indirect beneficial ownership over shares of the Issuer's common stock held by Intervac and BioVac. After giving effect to the Distribution, the reporting person no longer has beneficial ownership over 164,610 shares of the Issuer's common stock that was previously reported as beneficially owned by BioVac. F3 · ownership.nature: Held by the El-Hibri Family Trust, for which the reporting person's wife serves as the Trustee. The reporting person expressly disclaims beneficial ownership of any shares of the Issuer's common stock owned by the El Hibri Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| December 03, 2021 Filed Dec 8, 2021 02:10 UTC |
El-Hibri FuadDirector
|
OtherCommon Stock | 3,018,644 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-047222 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,018,644 F1 · kind: On December 3, 2021, each of Intervac L.L.C., a Maryland limited liability company ("Intervac"), and BioVac, L.L.C., a Maryland limited liability company ("BioVac"), effected a pro-rata liquidating distribution to their respective members of shares of the Issuer's common stock for no consideration (the "Distribution"). In prior reports filed by the reporting person pursuant to Section 16, the reporting person reported indirect beneficial ownership over shares of the Issuer's common stock held by Intervac and BioVac. After giving effect to the Distribution, the reporting person no longer has beneficial ownership over 164,610 shares of the Issuer's common stock that was previously reported as beneficially owned by BioVac. F2 · ownership.nature: Held by the Yahia Fuad El-Hibri Revocable Trust, for which the reporting person serves as the Trustee. Comprised of (i) 1,659,099 shares of the Issuer's common stock previously reported as beneficially owned by Intervac and (ii) 1,359,545 shares of the Issuer's common stock previously reported as beneficially owned by BioVac. The reporting person expressly disclaims beneficial ownership of any shares of the Issuer's common stock owned by the Yahia Fuad El-Hibri Revocable Trust except to the extent of his pecuniary interest therein. Read SEC document |
| November 15, 2021 Filed Nov 15, 2021 22:53 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
PurchaseCommon Stock | 3,000 | $37.46 | $112,380.00 |
DisclosureSEC source: 0001367644-21-000144 · wf-form4_163701676472498.xml · nonDerivative · entry 1 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,919 F1 · price: The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $37.32 to $37.63. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:37 UTC |
Zoon Kathryn CDirector
|
SaleCommon Stock | 3,139 | $56.48 | $177,290.72 |
DisclosureSEC source: 0001367644-21-000101 · wf-form4_162214773924582.xml · nonDerivative · entry 1 Zoon Kathryn C · CIK 0001685720 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,377 F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. F2 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). F3 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.11 to $56.86. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:11 UTC |
Zoon Kathryn CDirector
|
GrantCommon Stock | 5,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000095 · wf-form4_162189066691622.xml · nonDerivative · entry 1 Zoon Kathryn C · CIK 0001685720 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,516 F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:01 UTC |
White Marvin LDirector
|
GrantCommon Stock | 5,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000087 · wf-form4_162189005445348.xml · nonDerivative · entry 1 White Marvin L · CIK 0001493324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,656 F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company. Read SEC document |
| May 20, 2021 Filed May 24, 2021 16:58 UTC |
Hauer Jerome MDirector
|
GrantCommon Stock | 5,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000085 · wf-form4_162188987773805.xml · nonDerivative · entry 1 Hauer Jerome M · CIK 0001294935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,215 F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company. Read SEC document |
| May 20, 2021 Filed May 24, 2021 17:03 UTC |
JOULWAN GEORGE ADirector
|
GrantCommon Stock | 5,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000089 · wf-form4_162189019421132.xml · nonDerivative · entry 1 JOULWAN GEORGE A · CIK 0001222197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,798 F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:14 UTC |
SULLIVAN LOUIS WDirector
|
GrantCommon Stock | 5,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000097 · wf-form4_162189081830999.xml · nonDerivative · entry 1 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,972 F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.